Patent: 10,047,141
✉ Email this page to a colleague
Summary for Patent: 10,047,141
Title: | Method of manufacturing a protein by perfusion in media with a low amino acid concentration |
Abstract: | Perfusion media are disclosed providing excellent cell density, titer and product quality for production of a therapeutic protein in a perfusion process. |
Inventor(s): | Puchacz; Ela (Pleasanton, CA), Grove; James Russell (Mountain View, CA) |
Assignee: | Coherus Biosciences, Inc. (Redwood City, CA) |
Application Number: | 14/609,225 |
Patent Claims: | see list of patent claims |
Details for Patent 10,047,141
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Janssen Biotech, Inc. | REMICADE | infliximab | For Injection | 103772 | 08/24/1998 | ⤷ Try a Trial | 2039-02-26 |
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 11/02/1998 | ⤷ Try a Trial | 2039-02-26 |
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 05/27/1999 | ⤷ Try a Trial | 2039-02-26 |
Immunex Corporation | ENBREL | etanercept | Injection | 103795 | 09/27/2004 | ⤷ Try a Trial | 2039-02-26 |
Immunex Corporation | ENBREL | etanercept | Injection | 103795 | 02/01/2007 | ⤷ Try a Trial | 2039-02-26 |
Immunex Corporation | ENBREL MINI | etanercept | Injection | 103795 | 09/14/2017 | ⤷ Try a Trial | 2039-02-26 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |